ZVRA · Company research
Zevra Therapeutics, Inc. Common Stock (ZVRA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 10.73 | $695,557,236.78 | 550236236.78 | 81.0000000000000000 | — | — | — | 3.1957309686104424 | 31.16994115079542908318 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.